Gaggar S, Scott J, Thompson N. Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.
World J Gastrointest Pharmacol Ther 2012;
3:97-9. [PMID:
23494865 PMCID:
PMC3596519 DOI:
10.4292/wjgpt.v3.i6.97]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2012] [Revised: 10/08/2012] [Accepted: 11/20/2012] [Indexed: 02/06/2023] Open
Abstract
Gastroduodenal Crohn’s disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD.
Collapse